NASDAQ · BRTX

BioRestorative Therapies, Inc.

Closing price · Nov 13, 2026 $1.49

Latest quarter · ended Mar 31, 2026

Sales slipped and cash got weaker

descriptionFiled May 14, 2026
Revenue growthShrinking
−7.3%
Quarter ended Jun 30, 2024: +38.1% sales vs. a year beforeQuarter ended Sep 30, 2024: +660.9% sales vs. a year beforeQuarter ended Dec 31, 2024: +124.4% sales vs. a year beforeQuarter ended Mar 31, 2025: −28.6% sales vs. a year beforeQuarter ended Jun 30, 2025: +240.4% sales vs. a year beforeQuarter ended Sep 30, 2025: −94.9% sales vs. a year beforeQuarter ended Dec 31, 2025: −54.7% sales vs. a year beforeQuarter ended Mar 31, 2026: −7.3% sales vs. a year before
Jun '24Mar '26
$23.2K vs. $25K a year ago
Gross marginWorse
68.1%
Quarter ended Jun 30, 2024: 92.7% gross marginQuarter ended Sep 30, 2024: 92.2% gross marginQuarter ended Dec 31, 2024: 92.3% gross marginQuarter ended Mar 31, 2025: 88.4% gross marginQuarter ended Jun 30, 2025: 97.1% gross marginQuarter ended Sep 30, 2025: 10.4% gross marginQuarter ended Dec 31, 2025: 91.7% gross marginQuarter ended Mar 31, 2026: 68.1% gross margin
Jun '24Mar '26
vs. 88.4% a year ago
Cash from operationsWorse
−$3.81M
Quarter ended Jun 30, 2024: −$1.87M cash from operationsQuarter ended Sep 30, 2024: −$1.7M cash from operationsQuarter ended Dec 31, 2024: −$2.35M cash from operationsQuarter ended Mar 31, 2025: −$2.78M cash from operationsQuarter ended Jun 30, 2025: −$2.69M cash from operationsQuarter ended Sep 30, 2025: −$2.9M cash from operationsQuarter ended Dec 31, 2025: −$2.42M cash from operationsQuarter ended Mar 31, 2026: −$3.81M cash from operations
Jun '24Mar '26
vs. −$2.78M a year ago
Share countDiluting
+239.5%
Quarter ended Jun 30, 2024: 6.92M sharesQuarter ended Sep 30, 2024: 6.92M sharesQuarter ended Dec 31, 2024: 7.5M sharesQuarter ended Mar 31, 2025: 7.5M sharesQuarter ended Jun 30, 2025: 7.98M sharesQuarter ended Sep 30, 2025: 8.88M sharesQuarter ended Dec 31, 2025: 25.48M sharesQuarter ended Mar 31, 2026: 25.48M shares
Jun '24Mar '26
25.48M shares vs. 7.5M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

21 funds report owning BRTX, up from 11

Holdings as of Jun 30, 2026
New10
Added3
Held6
Trimmed2
Sold out0

Insider trades · last 12 months

Real buys and sales

No insider filings loaded for the last 12 months.

Top holders

Biggest funds in BRTX

As of Jun 30, 2026
FundOwnsValueChange
Jane Street Group, LLC3.2%$302KNew
HRT Financial LP2.8%$267KNew
XTX Topco Ltd1.1%$108KNew
Citadel Advisors LLC1.1%$103K+15%
Vanguard Fiduciary Trust Co0.7%$68.2K+360%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist